Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2024-07-02 Regulatory Filings
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
LIFE: Cleanroom arrived in Hamburg
Regulatory Filings Classification · 1% confidence The document is a short announcement from Lifecare ASA dated July 2, 2024, detailing the arrival of a cleanroom in Hamburg and rescheduling the Pilot Production Site launch to Q3 2024. It provides operational updates related to manufacturing and includes contact information. It is not a formal financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). It is a specific operational update that doesn't fit the definitions for AGM-R, AR, MANG, CT, CAP, DVA, DLST, DIRS, SR, FS, CGR, IRAT, IP, LTR, TAR, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. Since it is a general, non-standard regulatory announcement concerning company operations and progress, the most appropriate fallback category is Regulatory Filings (RNS). The document length (2463 chars) is short, but it is providing substantive news rather than just announcing another report, making RNS a better fit than RPA.
2024-07-02 English
LIFE: Cleanroom arrived in Hamburg
Regulatory Filings Classification · 1% confidence The document is a short announcement from Lifecare ASA regarding the arrival of its cleanroom equipment in Hamburg, which is necessary for automated production of its CGM sensors. It provides an update on a previously announced purchase order and mentions a resulting schedule change for pilot production (aiming for Q3 2024). This is a specific operational update concerning production capability and scheduling, not a full financial report (10-K, IR), an earnings release (ER), or a formal regulatory filing like a DIRS or MRQ. Since it is a specific operational announcement that doesn't fit the other specialized categories (like M&A, DIV, CAP), it best fits the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory or significant operational announcements not covered elsewhere. Given its brevity and nature as an update, RNS is the most appropriate classification.
2024-07-02 English
LIFE: Successfully completed first week of longevity trials
Regulatory Filings Classification · 1% confidence The document is a press release dated June 27, 2024, announcing positive preliminary results from the first week of sensor longevity trials for a new Continuous Glucose Monitor (CGM) technology. It contains quotes from management, details about the trial progress (involving a dog named Elli), and background information about the company (Lifecare ASA). This format—a short, timely announcement of operational or preliminary results—is characteristic of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not a full financial report (like 10-K or IR), nor a specific management discussion (MDA), nor a formal dividend/share change notice, it fits best as a general announcement. Given the content is focused on operational progress and preliminary results, it is most closely aligned with an Earnings Release (ER) if it were tied to a reporting period, but since it is a specific operational update, the most appropriate general category for non-standard, timely announcements is Regulatory Filings (RNS). However, because it details 'positive results' from trials, which often accompany or precede formal earnings reports, and given its brevity (3325 chars) and press release format, RNS is the safest fallback, although ER might be considered if this were a quarterly update summary. Since it's a specific operational milestone announcement, RNS is the most fitting general regulatory announcement category.
2024-06-27 English
LIFE: Successfully completed first week of longevity trials
Regulatory Filings Classification · 1% confidence The document is a press release dated June 27, 2024, from Lifecare ASA announcing positive preliminary results from the first week of sensor longevity trials for their Continuous Glucose Monitor (CGM) technology in a dog named Elli. It details technical progress, quotes management, and mentions future steps (expanding the study, using a reference monitor). This type of announcement, focusing on operational or clinical progress rather than formal financial results (like 10-K or ER), typically falls under general regulatory announcements or news releases. Since it is not a formal financial report, a management discussion, a board change, or a specific financing event, the most appropriate general category is Regulatory Filings (RNS), which serves as a broad category for significant operational news releases that don't fit elsewhere. It is too detailed to be a simple Report Publication Announcement (RPA) and does not match any other specific financial filing type.
2024-06-27 English
Lifecare ASA: Information about the warrants issued in connection with the Rights Issue
Capital/Financing Update Classification · 1% confidence The document discusses the allocation and terms of Warrants issued in connection with a Rights Issue, including exercise periods, listing details, and potential proceeds. This content relates directly to changes in the company's capital structure and fundraising activities. It is an announcement detailing the outcome and mechanics of a financing event. This aligns best with the 'Capital/Financing Update' category (CAP), as it details the structure and expected proceeds from the capital raise mechanism (warrants linked to a rights issue). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific announcement about capital structure changes.
2024-06-27 English
Lifecare ASA: Information about the warrants issued in connection with the Rights Issue
Capital/Financing Update Classification · 1% confidence The document discusses the allocation and terms of warrants issued in connection with a Rights Issue, including details on exercise periods, listing, and expected proceeds. This content directly relates to changes in the company's capital structure and fundraising activities. This aligns best with the 'Capital/Financing Update' category (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it details a specific financing event.
2024-06-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.